Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Patient-reported Outcome (PRO) Measure That Assesses Reasons for Non-adherence to Growth Hormone Therapy (GHT)

NCT03672617 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT03672617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03672617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Patient-reported Outcome (PRO) Measure That Assesses Reasons for Non-adherence to Growth Hormone Therapy (GHT)
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
October 2, 2018
Completion date
April 25, 2019
Enrollment
321 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency in children